Join MediWound for a virtual Key Opinion Leader (KOL) event to discuss EscharEx^®, an innovative treatment in late-stage clinical development for chronic wound debridement, with a focus on its upcoming Phase III VALUE study in venous leg ulcers (VLUs).

The event will feature three distinguished experts:

• John C. Lantis II, MD | Icahn School of Medicine at Mount Sinai
• Vickie R. Driver, DPM, MS | Washington State University
• Robert J. Snyder, DPM, MBA | Barry University School of Podiatric Medicine

The experts will discuss the following topics:

• The significant unmet need and current treatment landscape for VLUs and diabetic foot ulcers (DFUs)
• Compelling results to date from the Phase II studies of EscharEx
• The upcoming Phase III VALUE study of EscharEx in VLUs
• EscharEx’s competitive advantages and its unique commercial potential

A live Q&A session will follow the presentations, providing an opportunity for attendees to engage directly with our experts.